 Patients with a presence of Promyelocytic Leukemia-Retinoic Acid Receptor Alpha (PML-RARA) genes rearrangement predict a favorable response to all-trans retinoic acid (ATRA), and a significant improvement in survival.     ///    "Therefore, establishing the presence of PML-RARA rearrangement is important for optimal patient management. "